The UK High Court rules that complying with a court-ordered disclosure in patent infringement proceedings between pharmaceutical companies does not breach competition law (Teva / Chiesi)

L'Ecluse, Peter

Previous article The French Competition Authority publishes a study on competition and e-commerce Next article The EU Commission seeks stakeholders comments to obtain market investigation powers in the form of a “New Competition Tool”

2 Jun 2020

The UK High Court rules that complying with a court-ordered disclosure in patent infringement proceedings between pharmaceutical companies does not breach competition law (Teva / Chiesi)

KEYWORDS

Reference

UK High Court, Teva / Chiesi, [2020] EWHC 1311 (Pat), 2 June 2020

On 2 June 2020, the UK High Court delivered a judgment in a case pitting pharmaceutical companies Teva UK Limited (“Teva”) against Chiesi Farmaceutici (“Chiesi”) in which Mr Justice Birss ruled that complying with a court-ordered disclosure in patent infringement proceedings does not breach Article 101 of the Treaty on the Functioning of the European Union (“TFEU”) and the equivalent provisions of the UK Competition Act. In October 2019, Teva brought an action against Chiesi seeking to have three patents held by Chiesi over asthma treatments

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

PDF Version

Author

Peter L’Ecluse
Van Bael & Bellis (Brussels)

Belgium 125 contributions 35645 visits

Quotation

Peter L'Ecluse, The UK High Court rules that complying with a court-ordered disclosure in patent infringement proceedings between pharmaceutical companies does not breach competition law (Teva / Chiesi), 2 June 2020, e-Competitions June 2020, Art. N° 95715

Visites 85